Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ENXTPA:CA
ENXTPA:CAConsumer Retailing

Is Carrefour’s Share Price Rally in 2025 Justified After Its Recent Earnings Recovery?

If you own Carrefour stock or you’re thinking about jumping in, you might be wondering what’s next for this retail heavyweight. Over the past month, Carrefour’s share price has climbed a sturdy 10.1%, putting a spring in the step of anyone watching for signs of growth. Even over the past week, the stock notched up another 3.3%. Despite these recent gains, the stock is still down 2.3% so far this year and trails by 4.0% over the last twelve months. Looking further back, there is a respectable...
NYSE:FR
NYSE:FRIndustrial REITs

First Industrial Realty Trust (FR): Margin Drop Reinforces Investor Caution on Growth Story

First Industrial Realty Trust (FR) posted a net profit margin of 33.2%, a step down from last year's 47% margin. The five-year average annual earnings growth sits at 3.7%. Looking ahead, the company expects earnings to grow at 5.05% per year and revenue at 7.2% per year, both trailing the broader US market's expected growth. Investors will be closely watching how First Industrial balances profitability and growth in the face of ongoing margin pressures and a financial position flagged as a...
NYSE:NMAX
NYSE:NMAXMedia

What Recent Price Swings Mean for Newsmax Stock in 2025

Thinking about what to do with Newsmax stock? You’re not alone; this is the question on the minds of many investors right now. Newsmax has been in the spotlight due to some sharp price swings, and whether you’re already holding shares or considering jumping in, it’s important to look past the headlines and dig into what’s really happening with this stock. In the past month, Newsmax shares have dropped 13.7%, adding to a tough year-to-date slide of 86.7%. Over the last week, things have been...
NasdaqGS:NTGR
NasdaqGS:NTGRCommunications

A Fresh Look at NETGEAR (NTGR) Valuation Following Recent Share Price Gains

NETGEAR (NTGR) shares have seen some interesting movement recently, with the stock gaining over 13% in the past month. Investors may be weighing the company’s steady annual revenue growth as well as ongoing changes in the tech sector. See our latest analysis for NETGEAR. While NETGEAR's 1-month share price return of 13.2% signals renewed momentum, the stock's 1-year total shareholder return stands at an impressive 50.7%. This suggests that although gains have recently accelerated, long-term...
ASX:MGX
ASX:MGXMetals and Mining

IPD Group And 2 Other ASX Penny Stocks To Consider

The Australian market is facing a potential decline, influenced by the rising gold prices and weaker-than-expected jobs data, which could keep the indices within the 9,000 range. Amid these conditions, investors often look for opportunities that balance risk and reward, making penny stocks an intriguing option. Although considered a vintage term, penny stocks can still offer significant value when backed by robust financials and solid fundamentals.
TSX:URC
TSX:URCOil and Gas

A Look at Uranium Royalty Corp. (TSX:URC) Valuation Following First Profitable Quarter and 52-Week High

Uranium Royalty (TSX:URC) just posted its first-ever profitable quarter, capturing the spotlight as revenue and earnings landed above forecasts. This milestone arrives as uranium prices climb and sector momentum builds globally. See our latest analysis for Uranium Royalty. Momentum is clearly with Uranium Royalty right now. After hitting a new 52-week high on the back of surging uranium prices and its first profitable quarter, the company’s one-year total shareholder return stands at an...
NasdaqCM:BLFS
NasdaqCM:BLFSLife Sciences

Is There Still Opportunity in BioLife Solutions After 15% Share Price Gain in 2025?

Thinking about what to do next with BioLife Solutions stock? You are not alone. Over the past year, shares have quietly climbed 15.6%, and while that performance might catch your eye, it is the bigger context that makes this stock so interesting right now. Investors have watched it rebound 6.8% in just the last 30 days, adding to a 4.4% gain year-to-date. Yet, when looking further back, the five-year total return lags at -5.9%, painting a far more complex picture. So, what is driving this...
HLSE:ALMA
HLSE:ALMAMedia

Alma Media Oyj (HLSE:ALMA) Is Up 7.5% After Upward 2025 Revenue Guidance Revision - What's Changed

On October 14, 2025, Alma Media Corporation revised its earnings guidance, announcing that its 2025 revenue is now expected to remain at or exceed the 2024 level of €312.7 million, rather than remaining flat as previously projected. This updated forecast highlights Alma Media's continued favorable business performance and the positive impact of recent acquisitions, particularly Edilex Oy and Effortia Oy, amid ongoing market uncertainty. We'll explore how Alma Media's upward revenue guidance...
NasdaqGS:MANH
NasdaqGS:MANHSoftware

Is Manhattan Associates Ready to Rebound After 34% Slide and Post-Earnings Downturn?

If you’re wondering what to do about Manhattan Associates stock at this crossroads, you’re in good company. The once high-flying supply chain software specialist has caught the attention of investors trying to make sense of recent swings. Despite an impressive 54.3% three-year return and a remarkable 101.9% gain over five years, the stock is now catching its breath. Over the past month, shares have slipped by 8.4%, pushing year-to-date performance down to -26.8%, with a full-year drop to...
NasdaqCM:CYRX
NasdaqCM:CYRXLife Sciences

Could Cryoport's (CYRX) New Monitoring Tech Reveal Its Strategy for Digital Cold Chain Leadership?

Cryoport, Inc. recently unveiled new integrated condition monitoring solutions for its MVE Biological Solutions dewars, incorporating the SmartTag and CryoBeacon devices powered by Tec4Med, with data centralized in the FDA-compliant MVECloud platform for enhanced monitoring of cryogenic storage. This innovation offers life sciences companies real-time visibility and improved safety for temperature-sensitive commodities, reflecting an ongoing push toward advanced digital and compliance...
NasdaqGM:QSI
NasdaqGM:QSILife Sciences

Can Quantum-Si's (QSI) V4 Kit Innovation Deepen Its Edge in the Protein Sequencing Race?

Quantum-Si recently introduced its V4 Sequencing Kit, designed to enhance protein analysis by expanding sequencing coverage and improving detection of specific amino acids. This technological advance stands out for its potential to significantly strengthen the company’s protein sequencing platform in the evolving life sciences sector. We'll look at how the V4 Sequencing Kit's improved capabilities shape Quantum-Si's investment narrative amid shifting market attention. Find companies with...
SEHK:1177
SEHK:1177Pharmaceuticals

Does Sino Biopharm Offer Value After Jumping 135% and Expanding in Asia in 2025?

If you have been watching Sino Biopharmaceutical, you are probably wondering what to make of this stock after such a rollercoaster ride. The past year has brought a surge that few predicted, with the stock up an eye-catching 135.6% since the start of the year and 95.3% over the last twelve months. Even looking back three years, the company has notched an impressive 83.5% gain. Yet, this momentum hit a speed bump recently, with prices dropping 6.7% in the last week and falling 13.2% over the...
NasdaqCM:RCEL
NasdaqCM:RCELBiotechs

A Look at AVITA Medical (RCEL) Valuation Following CEO Change and Preliminary Q3 Revenue Miss

AVITA Medical (RCEL) shares have drawn attention after Chairman Cary Vance was named Interim CEO, replacing Jim Corbett. This leadership shift comes as preliminary third-quarter revenue comes in below expectations and ongoing talks with lenders continue. See our latest analysis for AVITA Medical. Shares of AVITA Medical have struggled through 2025, with the 1-day share price return plunging 25.84% after the CEO transition and softer revenue update. Short-term momentum has clearly faded. With...
HLSE:TNOM
HLSE:TNOMProfessional Services

Talenom (HLSE:TNOM) Earnings Growth of 61.8% Reinforces Turnaround Narrative

Talenom Oyj (HLSE:TNOM) delivered headline numbers that point to a turnaround story, with revenue forecast to grow 7.7% per year, well above the Finnish market's 4% annual pace. EPS momentum is clear, as the company posted a striking 61.8% earnings growth rate over the past year, compared to a five-year average of negative 14.2% per year. Net profit margins now stand at 4.8% versus last year's 3%, underscoring an improvement in underlying profitability and the quality of earnings. See our...